SMI Expanded
1.728,70
PKT
-0,69
PKT
-0,04
%
Werbung
Analysen zu SMI Expanded-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.04.21 | Holcim overweight | Morgan Stanley | |
07.04.21 | Swiss Re buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.04.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
07.04.21 | UBS Neutral | UBS AG | |
07.04.21 | UBS Neutral | Goldman Sachs Group Inc. | |
07.04.21 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
07.04.21 | UBS Outperform | Credit Suisse Group | |
07.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
07.04.21 | UBS Sector Perform | RBC Capital Markets | |
06.04.21 | UBS Neutral | JP Morgan Chase & Co. | |
06.04.21 | Givaudan Sell | Goldman Sachs Group Inc. | |
06.04.21 | UBS Halten | DZ BANK | |
06.04.21 | UBS Sector Perform | RBC Capital Markets | |
06.04.21 | UBS overweight | JP Morgan Chase & Co. | |
06.04.21 | UBS kaufen | JP Morgan Chase & Co. | |
06.04.21 | ABB (Asea Brown Boveri) buy | Goldman Sachs Group Inc. | |
31.03.21 | UBS Neutral | UBS AG | |
31.03.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
30.03.21 | Nestlé overweight | JP Morgan Chase & Co. | |
30.03.21 | UBS Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.03.21 | DocMorris Sell | UBS AG | |
30.03.21 | Zurich Insurance overweight | Barclays Capital | |
30.03.21 | UBS Neutral | Goldman Sachs Group Inc. | |
29.03.21 | Givaudan Hold | Deutsche Bank AG | |
29.03.21 | UBS kaufen | DZ BANK | |
26.03.21 | Nestlé buy | Goldman Sachs Group Inc. | |
25.03.21 | Holcim Hold | Jefferies & Company Inc. | |
25.03.21 | UBS Outperform | Credit Suisse Group | |
24.03.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
24.03.21 | Roche overweight | Barclays Capital | |
24.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
24.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
23.03.21 | DocMorris overweight | Morgan Stanley | |
23.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | DocMorris buy | Warburg Research | |
23.03.21 | Novartis buy | Jefferies & Company Inc. | |
23.03.21 | Novartis market-perform | Bernstein Research | |
23.03.21 | Roche Outperform | Bernstein Research |